Perma-Fix Reports Q1 2025 Results and Highlights Momentum in Hanford and PFAS Programs

Stock Information for Inhibikase Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Inhibikase Therapeutics Inc.

Perma-Fix Schedules First Quarter 2025 Business Update Conference Call
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
Perma-Fix to Present at Gabelli Funds' 11th Annual Waste & Environmental Services Symposium in New York City on April 3rd
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
Perma-Fix Reports Financial Results and Provides Business Update for Full Year and Fourth Quarter of 2024
Perma-Fix Schedules Fourth Quarter and Fiscal 2024 Business Update Conference Call
Perma-Fix Expands PFAS Treatment Operations to Meet Growing Demand

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.